$CRVW
CareView Communications Inc Stock $crvw

$crvw Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000199937123000144 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$1.767M	$2.425M
YoY Change	-7.88%	23.26%
Cost Of Revenue	$740.0K	$540.0K
YoY Change	101.55%	-27.09%
Gross Profit	$1.027M	$1.890M
YoY Change	-33.78%	54.03%
Gross Profit Margin	58.12%	77.93%
Selling, General & Admin	$1.017M	$1.108M
YoY Change	7.08%	7.66%
% of Gross Profit	99.0%	58.63%
Research & Development	$847.0K	$621.9K
YoY Change	189.85%	55.71%
% of Gross Profit	82.48%	32.91%
Depreciation & Amortization	$62.01K	$90.00K
YoY Change	-54.91%	-19.47%
% of Gross Profit	6.04%	4.76%
Operating Expenses	$1.975M	$2.469M
YoY Change	20.99%	7.35%
Operating Profit	-$948.1K	-$43.54K
YoY Change	1062.16%	-86.9%
Interest Expense	-$668.2K	$831.0K
YoY Change	-40.58%	-27.54%
% of Operating Profit
Other Income/Expense, Net		-$826.4K
YoY Change		-27.94%
Pretax Income	-$1.616M	-$869.9K
YoY Change	-670.37%	-41.19%
Income Tax	$74.52K
% Of Pretax Income
Net Earnings	-$1.691M	-$869.9K
YoY Change	-696.67%	-41.19%
Net Earnings / Revenue	-95.69%	-35.87%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	583.9M shares	583.9M shares
Diluted Shares Outstanding		583.9M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.146M	$670.0K
YoY Change	120.29%	131.97%
Cash & Equivalents	$1.146M	$674.0K
Short-Term Investments
Other Short-Term Assets	$335.1K	$329.8K
YoY Change	371.82%	372.62%
Inventory	$294.4K	$232.6K
Prepaid Expenses	$62.84K	$20.45K
Receivables	$1.168M	$1.826M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.943M	$3.062M
YoY Change	59.88%	89.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$610.6K	$375.5K
YoY Change	-4.97%	-51.12%
Goodwill
YoY Change
Intangibles	$406.3K	$738.9K
YoY Change	-50.46%	-20.43%
Long-Term Investments
YoY Change
Other Assets	$302.0K	$270.0K
YoY Change	-79.37%	-83.52%
Total Long-Term Assets	$1.319M	$1.716M
YoY Change	-37.39%	-28.7%
TOTAL ASSETS
Total Short-Term Assets	$2.943M	$3.062M
Total Long-Term Assets	$1.319M	$1.716M
Total Assets	$4.262M	$4.778M
YoY Change	7.97%	18.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$598.1K	$605.8K
YoY Change	-8.1%	-30.8%
Accrued Expenses	$17.10M	$16.46M
YoY Change	24.08%	27.97%
Deferred Revenue		$1.207M
YoY Change		24.0%
Short-Term Debt	$700.0K	$700.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$20.00M	$20.00M
YoY Change	-60.0%	-73.83%
Total Short-Term Liabilities	$40.21M	$39.02M
YoY Change	-39.15%	-57.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$318.0K	$151.2K
YoY Change	1254.33%	459.81%
Total Long-Term Liabilities	$318.0K	$334.5K
YoY Change	-97.81%	-98.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.21M	$39.02M
Total Long-Term Liabilities	$318.0K	$334.5K
Total Liabilities	$40.52M	$39.36M
YoY Change	-49.73%	-67.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$207.9M	-$206.2M
YoY Change	1.94%	0.97%
Common Stock	$171.6M	$583.9K
YoY Change	34.85%	318.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$36.26M	-$34.58M
YoY Change
Total Liabilities & Shareholders Equity	$4.262M	$4.778M
YoY Change	7.97%	18.91%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.691M	-$869.9K
YoY Change	-696.67%	-41.19%
Depreciation, Depletion And Amortization	$62.01K	$90.00K
YoY Change	-54.91%	-19.47%
Cash From Operating Activities	$533.6K	-$30.00K
YoY Change	-709.91%	-85.25%
INVESTING ACTIVITIES
Capital Expenditures	$6.790K	$10.00K
YoY Change	-111.65%	-236.24%
Acquisitions
YoY Change
Other Investing Activities	-$45.68K
YoY Change
Cash From Investing Activities	-$52.47K	-$10.00K
YoY Change	-190.06%	36.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.440K	0.000
YoY Change	-102.09%	-100.0%
NET CHANGE
Cash From Operating Activities	533.6K	-30.00K
Cash From Investing Activities	-52.47K	-10.00K
Cash From Financing Activities	-5.440K	0.000
Net Change In Cash	475.7K	-40.00K
YoY Change	105.64%	-81.33%
FREE CASH FLOW
Cash From Operating Activities	$533.6K	-$30.00K
Capital Expenditures	$6.790K	$10.00K
Free Cash Flow	$526.8K	-$40.00K
YoY Change	-1902.33%	-79.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001377149
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	crvw	Additions To Deferred Costs AdditionsToDeferredCosts		usd
	crvw	Additions To Deferred Costs AdditionsToDeferredCosts		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54090
	dei	Entity Registrant Name EntityRegistrantName	CAREVIEW COMMUNICATIONS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4659068
	dei	Entity Address Address Line1 EntityAddressAddressLine1	405 State Highway 121
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B-240
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lewisville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75067
	dei	City Area Code CityAreaCode	(972)
	dei	Local Phone Number LocalPhoneNumber	943-6050
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	CRVW
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	583880748	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	674020	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520166	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1825870	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	948328	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	232606	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	301446	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	329837	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71020	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	3062333	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1840960	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375526	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	642559	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	738863	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	820106	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	330477	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	434330	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	270847	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2023Q3	us-gaap	Assets Assets	4778046	usd
CY2022Q4	us-gaap	Assets Assets	3947604	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	605844	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	650796	usd
CY2023Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	20000000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	20000000	usd
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	700000	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	700000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	42394168	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1805832	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	185304	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	175520	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17532785	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14553277	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	39023933	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	80279593	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	183297	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	305259	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	151165	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23481	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	334462	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328740	usd
CY2023Q3	us-gaap	Liabilities Liabilities	39358395	usd
CY2022Q4	us-gaap	Liabilities Liabilities	80608333	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	583880748	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	583880748	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141880748	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141880748	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	583880	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	141881	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	171029956	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	127130055	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-206194185	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203932665	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-34580349	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4778046	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3947604	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2425390	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1967624	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7917758	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5983389	usd
CY2023Q3	us-gaap	Equipment Expense EquipmentExpense	105311	usd
CY2022Q3	us-gaap	Equipment Expense EquipmentExpense	39630	usd
	us-gaap	Equipment Expense EquipmentExpense	362241	usd
	us-gaap	Equipment Expense EquipmentExpense	157227	usd
CY2023Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	537779	usd
CY2022Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	602170	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	2006308	usd
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	1949153	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	684848	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	571658	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2434568	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2387898	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	423184	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	234414	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	822417	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	565382	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	621929	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	721339	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1655934	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1668883	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95874	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	130743	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	376502	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	443695	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2468925	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2299954	usd
	us-gaap	Operating Expenses OperatingExpenses	7657970	usd
	us-gaap	Operating Expenses OperatingExpenses	7172238	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-43535	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-332330	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	259788	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1188849	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	830994	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1146820	usd
	us-gaap	Interest Expense InterestExpense	2527955	usd
	us-gaap	Interest Expense InterestExpense	5137272	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4628	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	76	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6647	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	130	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-826366	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1146744	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2521308	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5137142	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-869901	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1479074	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2261520	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6325991	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-869901	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1479074	usd
	us-gaap	Profit Loss ProfitLoss	-2261520	usd
	us-gaap	Profit Loss ProfitLoss	-6325991	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	583880748	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	583880748	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139380748	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139380748	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	417517785	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	417517785	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139380748	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139380748	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-112698298	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	240000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	55847	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2345008	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-114747459	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	58363	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2501909	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-117191005	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	58858	usd
CY2022Q3	crvw	Related Party Interest Forgiveness RelatedPartyInterestForgiveness	1667260	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-1479074	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-116943961	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-76660729	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	62260	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	26200000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1346812	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-51745281	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	54796	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	18000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-44807	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-33735292	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	24844	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-869901	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-34580349	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2261520	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6325991	usd
	us-gaap	Depreciation Depreciation	273478	usd
	us-gaap	Depreciation Depreciation	375867	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	81242	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40098	usd
	crvw	Amortization Of Installation Costs AmortizationOfInstallationCosts	21783	usd
	crvw	Amortization Of Installation Costs AmortizationOfInstallationCosts	27730	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	860239	usd
	crvw	Noncash Lease Expense NoncashLeaseExpense	103853	usd
	crvw	Noncash Lease Expense NoncashLeaseExpense	88838	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	141900	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2080328	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	877542	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-69064	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-68840	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39960	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	258817	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-165732	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-12295	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-12295	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-44952	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	461222	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2406375	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2219923	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	616225	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-225486	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-112178	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-92497	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	170982	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-282598	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6444	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5189	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	58260	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6444	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63449	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	13786	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	10684	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	10567	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10684	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24353	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	153854	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-370400	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	520166	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	659228	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	674020	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	288828	usd
	us-gaap	Interest Paid Net InterestPaidNet	114291	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1667260	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.10
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	44200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7917758	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5983389	usd
CY2023Q3	crvw	Working Capital WorkingCapital	-36099968	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1345706	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1345706	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	33461	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	68901	usd
	crvw	Transfer To Expense TransferToExpense	21783	usd
	crvw	Transfer To Expense TransferToExpense	27731	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	11678	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Gross CapitalizedContractCostGross	41170	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46801922	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	222000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	46801922	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	600000	shares
	crvw	Stock Granted During Period Value Sharebased Compensation Gross Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGrossStockGrantedDuringPeriodValueSharebasedCompensationGross	33300	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	310000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	40817477	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Begining SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermBegining	P5Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	526425	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	600000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.03
	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P9Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	3000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	310000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.06
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	41107477	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.12
	crvw	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Ending SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding	P5Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	529425	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	40200144	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y9M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	523425	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	49028	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	309386	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	36639	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20451	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	34381	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	329837	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	71020	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	232606	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	301446	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	232606	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	301446	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13431398	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13424954	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13055872	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12782395	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375526	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	642559	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	273477	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	375867	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1234087	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	495224	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	738863	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1299746	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	479640	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	820106	usd
CY2023Q3	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	2016968	usd
CY2023Q3	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1746121	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	270847	usd
CY2022Q4	crvw	Other Assets Noncurrent Gross OtherAssetsNoncurrentGross	1812137	usd
CY2022Q4	crvw	Other Assets Accumulated Amortization OtherAssetsAccumulatedAmortization	1602488	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	209649	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	15258611	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	12933611	usd
CY2023Q3	crvw	Accrued Interest Related Parties AccruedInterestRelatedParties	418403	usd
CY2022Q4	crvw	Accrued Interest Related Parties AccruedInterestRelatedParties	337027	usd
CY2023Q3	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2022Q4	crvw	Allowance System Removal Current AllowanceSystemRemovalCurrent	54802	usd
CY2023Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	152291	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	154776	usd
CY2023Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	139041	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	139041	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1207338	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	890631	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	302299	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	43389	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17532785	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14553277	usd
CY2023Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P23M
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-08-31
CY2009Q3	crvw	Area Of Leased Property AreaOfLeasedProperty	10578	sqft
CY2009Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2015-06-30
CY2020Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-08-31
	us-gaap	Operating Lease Cost OperatingLeaseCost	221535	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	226108	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	54451	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	221069	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	150679	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	426199	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	57598	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	368601	usd

Files In Submission

Name	View Source	Status
0001999371-23-000144-index-headers.html	Edgar Link	pending
0001999371-23-000144-index.html	Edgar Link	pending
0001999371-23-000144.txt	Edgar Link	pending
0001999371-23-000144-xbrl.zip	Edgar Link	pending
crvw-10q_093023.htm	Edgar Link	pending
crvw-10q_093023.jpg	Edgar Link	pending
crvw-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
crvw-20230930_def.xml	Edgar Link	unprocessable
crvw-20230930_cal.xml	Edgar Link	unprocessable
crvw-20230930_lab.xml	Edgar Link	unprocessable
crvw-20230930_pre.xml	Edgar Link	unprocessable
crvw-10q_093023_htm.xml	Edgar Link	completed
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRVW
CareView Communications Inc Stock $crvw

2023 Q4 Form 10-Q Financial Statement

#000199937123000144 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW CareView Communications Inc Stock $crvw

2023 Q4 Form 10-Q Financial Statement

#000199937123000144 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRVW
CareView Communications Inc Stock $crvw